Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.
Please consider a small donation if you think this website provides you with relevant information
| Date | Title | Source |
|---|---|---|
| 2024-02-13 7:1:34 am | Precipio to Report $15.2M for FY-2023 (unaudited) Revenues, an increase of 60% YoY | GlobeNewsWire |
| 2024-02-06 7:0:0 am | Precipio and Cardinal Health Sign Distribution Agreement for its HemeScreen® Portfolio of Molecular assays for Cancer | GlobeNewswire |
| 2024-01-23 7:0:0 am | Precipio’s Q4-2023 Cash Burn From Operations (unaudited) drops below $100K for the full quarter | GlobeNewswire |
| 2024-01-17 7:30:0 am | Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan | GlobeNewswire |
| 2024-01-02 6:0:0 am | Precipio Announces Christina Valauri joins the Board of Directors | GlobeNewswire |
| 2023-12-14 1:30:0 pm | Precipio Management Shares Thoughts on 2023, and Looks Ahead To 2024 | GlobeNewswire |
| 2023-11-16 2:0:0 pm | Precipio Announces Q3-2023 Shareholder Update Call | GlobeNewswire |
| 2023-11-16 2:7:18 am | When Will Precipio, Inc. (NASDAQ:PRPO) Breakeven? | Simply Wall St. |
Please consider a small donation if you think this website provides you with relevant information